Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 1 |
---|
Ligand | BDBM201915 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | IMAP-FP Assay |
---|
IC50 | 0.4±n/a nM |
---|
Citation | Wilson, KJ; Witter, DJ; Siliphaivanh, P; Lipford, K; Sloman, D; Falcone, D; O'Boyle, B; Mansoor, UF; Lim, J; Methot, JL; Boyce, C; Chen, L; Daniels, MH; Fevrier, S; Huang, X; Kurukulasuriya, R; Tong, L; Zhou, W; Kozlowski, J; Maletic, MM; Shinkre, BA; Thatai, JT; Bakshi, RK; Karunakaran, GB Compounds that are ERK inhibitors US Patent US9233979 Publication Date 1/12/2016 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 1 |
---|
Name: | Mitogen-activated protein kinase 1 |
Synonyms: | ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK |
Type: | Ser/Thr Protein Kinase |
Mol. Mass.: | 41392.76 |
Organism: | Homo sapiens (Human) |
Description: | P28482 |
Residue: | 360 |
Sequence: | MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE
HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH
LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH
TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI
LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK
RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
|
|
|
BDBM201915 |
---|
n/a |
---|
Name | BDBM201915 |
Synonyms: | US9233979, 346 |
Type | Small organic molecule |
Emp. Form. | C20H24N6O2 |
Mol. Mass. | 380.4436 |
SMILES | COC[C@@H](NC(=O)Nc1cc2[nH]nc(NC3CCC3)c2cn1)c1ccccc1 |r| |
Structure |
|